These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21909416)

  • 1. The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus.
    von Hahn T; Schulze A; Chicano Wust I; Heidrich B; Becker T; Steinmann E; Helfritz FA; Rohrmann K; Urban S; Manns MP; Pietschmann T; Ciesek S
    PLoS One; 2011; 6(9):e24142. PubMed ID: 21909416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of sotrastaurin clinical pharmacokinetics.
    Kovarik JM; Slade A
    Ther Drug Monit; 2010 Oct; 32(5):540-3. PubMed ID: 20683390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.
    Evenou JP; Wagner J; Zenke G; Brinkmann V; Wagner K; Kovarik J; Welzenbach KA; Weitz-Schmidt G; Guntermann C; Towbin H; Cottens S; Kaminski S; Letschka T; Lutz-Nicoladoni C; Gruber T; Hermann-Kleiter N; Thuille N; Baier G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):792-801. PubMed ID: 19491325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotrastaurin, a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.
    Manicassamy S
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1225-35. PubMed ID: 19876790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.
    Capsoni F; Ongari AM; Reali E; Bosè F; Altomare GF
    Int J Immunopathol Pharmacol; 2012; 25(3):617-26. PubMed ID: 23058012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients.
    Budde K; Sommerer C; Becker T; Asderakis A; Pietruck F; Grinyo JM; Rigotti P; Dantal J; Ng J; Barten MJ; Weber M
    Am J Transplant; 2010 Mar; 10(3):571-81. PubMed ID: 20121745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein kinase C inhibitor sotrastaurin allows regulatory T cell function.
    de Weerd A; Kho M; Kraaijeveld R; Zuiderwijk J; Weimar W; Baan C
    Clin Exp Immunol; 2014 Feb; 175(2):296-304. PubMed ID: 24131367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
    Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.
    Matz M; Naik M; Mashreghi MF; Glander P; Neumayer HH; Budde K
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):103-13. PubMed ID: 21142580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
    Liu JP; Ye L; Wang X; Li JL; Ho WZ
    Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.
    Abdelnabi R; Staveness D; Near KE; Wender PA; Delang L; Neyts J; Leyssen P
    Biochem Pharmacol; 2016 Nov; 120():15-21. PubMed ID: 27664855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
    Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
    Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses.
    Kovarik JM; Stitah S; Slade A; Vitaliti A; Straube F; Grenet O; Winter S; Sfikas N; Seiberling M
    J Clin Pharmacol; 2010 Nov; 50(11):1260-6. PubMed ID: 20386017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C inhibition ameliorates posttransplantation preservation injury in rat renal transplants.
    Fuller TF; Kusch A; Chaykovska L; Catar R; Pützer J; Haller M; Troppmair J; Hoff U; Dragun D
    Transplantation; 2012 Oct; 94(7):679-86. PubMed ID: 22932117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
    Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major royal-jelly protein 2 and its isoform X1 are two novel safe inhibitors for hepatitis C and B viral entry and replication.
    Habashy NH; Abu-Serie MM
    Int J Biol Macromol; 2019 Dec; 141():1072-1087. PubMed ID: 31520705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection.
    Zhang K; Lai X; Song J; He L; Wang L; Ou G; Tian X; Wang L; Deng J; Zhang J; Li C; Zhuang H; Li T; Xiang K
    Antiviral Res; 2021 May; 189():105061. PubMed ID: 33705864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.